SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

Q: Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.

NYSE:SEM • US81619Q1058

16.37 USD

0 (0%)

At close: Apr 10, 2026

16.37 USD

0 (0%)

After Hours: 4/10/2026, 5:16:09 PM

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. SEM Profitability Analysis

1.1 Basic Checks

In the past year SEM was profitable.
SEM had a positive operating cash flow in the past year.
SEM had positive earnings in each of the past 5 years.
In the past 5 years SEM always reported a positive cash flow from operatings.

1.2 Ratios

SEM's Return On Assets of 2.44% is in line compared to the rest of the industry. SEM outperforms 58.00% of its industry peers.
SEM has a better Return On Equity (8.38%) than 64.00% of its industry peers.
The Return On Invested Capital of SEM (5.27%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for SEM is below the industry average of 8.74%.
The 3 year average ROIC (4.28%) for SEM is below the current ROIC(5.27%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	2.44%
ROE	8.38%
ROIC	5.27%

ROA(3y)3.12%

ROA(5y)3.34%

ROE(3y)13.23%

ROE(5y)17.79%

ROIC(3y)4.28%

ROIC(5y)4.69%

1.3 Margins

SEM has a Profit Margin of 2.62%. This is in the better half of the industry: SEM outperforms 64.00% of its industry peers.
SEM's Profit Margin has declined in the last couple of years.
SEM has a better Operating Margin (6.17%) than 69.00% of its industry peers.
In the last couple of years the Operating Margin of SEM has declined.
SEM's Gross Margin of 11.54% is on the low side compared to the rest of the industry. SEM is outperformed by 71.00% of its industry peers.
SEM's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	6.17%
PM (TTM)	2.62%
GM	11.54%

OM growth 3Y25.21%

OM growth 5Y-6.51%

PM growth 3Y-8.86%

PM growth 5Y-10.34%

GM growth 3Y9.83%

GM growth 5Y-4.91%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. SEM Health Analysis

2.1 Basic Checks

SEM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SEM has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SEM has been reduced compared to 5 years ago.
The debt/assets ratio for SEM is higher compared to a year ago.

2.2 Solvency

SEM has an Altman-Z score of 1.62. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
SEM has a Altman-Z score (1.62) which is in line with its industry peers.
The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.74, SEM is doing worse than 62.00% of the companies in the same industry.
SEM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
SEM has a worse Debt to Equity ratio (1.07) than 61.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	15.74
Altman-Z	1.62

ROIC/WACC0.61

WACC8.57%

2.3 Liquidity

A Current Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.04, SEM is doing worse than 69.00% of the companies in the same industry.
SEM has a Quick Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
SEM has a worse Quick ratio (1.04) than 61.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.04
Quick Ratio	1.04

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. SEM Growth Analysis

3.1 Past

SEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.30%.
Measured over the past years, SEM shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.36% on average per year.
The Revenue has been growing slightly by 5.12% in the past year.
The Revenue has been decreasing by -0.29% on average over the past years.

EPS 1Y (TTM)-30.3%

EPS 3Y-2.22%

EPS 5Y-9.36%

EPS Q2Q%223.08%

Revenue 1Y (TTM)5.12%

Revenue growth 3Y5.76%

Revenue growth 5Y-0.29%

Sales Q2Q%6.41%

3.2 Future

SEM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.12% yearly.
SEM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.75% yearly.

EPS Next Y13.52%

EPS Next 2Y11.19%

EPS Next 3Y8.12%

EPS Next 5YN/A

Revenue Next Year5.04%

Revenue Next 2Y4.91%

Revenue Next 3Y4.75%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks Show best growing peers

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.23 indicates a correct valuation of SEM.
81.00% of the companies in the same industry are more expensive than SEM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SEM to the average of the S&P500 Index (26.78), we can say SEM is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.54, SEM is valued correctly.
SEM's Price/Forward Earnings ratio is rather cheap when compared to the industry. SEM is cheaper than 82.00% of the companies in the same industry.
SEM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.

		Industry Rank	Sector Rank
PE	14.23
Fwd PE	12.54

4.2 Price Multiples

80.00% of the companies in the same industry are more expensive than SEM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 67.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	17.32
EV/EBITDA	8.04

4.3 Compensation for Growth

SEM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.05

PEG (5Y)N/A

EPS Next 2Y11.19%

EPS Next 3Y8.12%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. SEM Dividend Analysis

5.1 Amount

SEM has a Yearly Dividend Yield of 1.53%.
Compared to an average industry Dividend Yield of 0.50, SEM pays a better dividend. On top of this SEM pays more dividend than 88.00% of the companies listed in the same industry.
SEM's Dividend Yield is comparable with the S&P500 average which is at 1.89.

		Industry Rank	Sector Rank
Dividend Yield	1.53%

5.2 History

SEM has paid a dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

21.99% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.

DP21.99%

EPS Next 2Y11.19%

EPS Next 3Y8.12%

More info and screens

Find the best dividend stocks Show peers with best dividend

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (4/10/2026, 5:16:09 PM)

After market: 16.37 0 (0%)

16.37

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)02-19 2026-02-19/amc

Earnings (Next)04-30 2026-04-30/amc

Inst Owners82.51%

Inst Owner Change0%

Ins Owners11.15%

Ins Owner Change0.41%

Market Cap2.03B

Revenue(TTM)5.45B

Net Income(TTM)142.92M

Analysts71.11

Price Target17.03 (4.03%)

Short Float %2.21%

Short Ratio1.06

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.53%

Yearly Dividend0.25

Dividend Growth(5Y)N/A

DP21.99%

Div Incr Years0

Div Non Decr Years0

Ex-Date03-02 2026-03-02 (0.0625)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)9.41%

Min EPS beat(2)-31%

Max EPS beat(2)49.82%

EPS beat(4)2

Avg EPS beat(4)11.24%

Min EPS beat(4)-31%

Max EPS beat(4)49.82%

EPS beat(8)3

Avg EPS beat(8)-11.03%

EPS beat(12)7

Avg EPS beat(12)-1.92%

EPS beat(16)8

Avg EPS beat(16)-6.67%

Revenue beat(2)2

Avg Revenue beat(2)1.44%

Min Revenue beat(2)1.43%

Max Revenue beat(2)1.45%

Revenue beat(4)2

Avg Revenue beat(4)-0.51%

Min Revenue beat(4)-3.62%

Max Revenue beat(4)1.45%

Revenue beat(8)4

Avg Revenue beat(8)-1.37%

Revenue beat(12)8

Avg Revenue beat(12)-0.69%

Revenue beat(16)10

Avg Revenue beat(16)5.67%

PT rev (1m)-4.75%

PT rev (3m)-8.07%

EPS NQ rev (1m)-2.12%

EPS NQ rev (3m)4.63%

EPS NY rev (1m)0%

EPS NY rev (3m)-1.9%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-0.21%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.68%

Valuation

		Industry Rank	Sector Rank
PE	14.23
Fwd PE	12.54
P/S	0.37
P/FCF	17.32
P/OCF	5.86
P/B	1.19
P/tB	N/A
EV/EBITDA	8.04

EPS(TTM)1.15

EY7.03%

EPS(NY)1.31

Fwd EY7.97%

FCF(TTM)0.95

FCFY5.77%

OCF(TTM)2.79

OCFY17.07%

SpS43.97

BVpS13.75

TBVpS-6.1

PEG (NY)1.05

PEG (5Y)N/A

Graham Number18.86

Profitability

		Industry Rank	Sector Rank
ROA	2.44%
ROE	8.38%
ROCE	6.91%
ROIC	5.27%
ROICexc	5.3%
ROICexgc	10.74%
OM	6.17%
PM (TTM)	2.62%
GM	11.54%
FCFM	2.15%

ROA(3y)3.12%

ROA(5y)3.34%

ROE(3y)13.23%

ROE(5y)17.79%

ROIC(3y)4.28%

ROIC(5y)4.69%

ROICexc(3y)4.32%

ROICexc(5y)4.74%

ROICexgc(3y)8.45%

ROICexgc(5y)10.81%

ROCE(3y)5.62%

ROCE(5y)6.16%

ROICexgc growth 3Y36.24%

ROICexgc growth 5Y-11.26%

ROICexc growth 3Y45.51%

ROICexc growth 5Y-3.96%

OM growth 3Y25.21%

OM growth 5Y-6.51%

PM growth 3Y-8.86%

PM growth 5Y-10.34%

GM growth 3Y9.83%

GM growth 5Y-4.91%

F-Score5

Asset Turnover0.93

Health

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	15.74
Debt/EBITDA	3.82
Cap/Depr	163.38%
Cap/Sales	4.2%
Interest Coverage	2.79
Cash Conversion	72.71%
Profit Quality	82.03%
Current Ratio	1.04
Quick Ratio	1.04
Altman-Z	1.62

F-Score5

WACC8.57%

ROIC/WACC0.61

Cap/Depr(3y)127.38%

Cap/Depr(5y)112.75%

Cap/Sales(3y)4.41%

Cap/Sales(5y)4.06%

Profit Quality(3y)122.64%

Profit Quality(5y)96.78%

High Growth Momentum

Growth

EPS 1Y (TTM)-30.3%

EPS 3Y-2.22%

EPS 5Y-9.36%

EPS Q2Q%223.08%

EPS Next Y13.52%

EPS Next 2Y11.19%

EPS Next 3Y8.12%

EPS Next 5YN/A

Revenue 1Y (TTM)5.12%

Revenue growth 3Y5.76%

Revenue growth 5Y-0.29%

Sales Q2Q%6.41%

Revenue Next Year5.04%

Revenue Next 2Y4.91%

Revenue Next 3Y4.75%

Revenue Next 5YN/A

EBIT growth 1Y25.29%

EBIT growth 3Y32.43%

EBIT growth 5Y-6.78%

EBIT Next Year43.55%

EBIT Next 3Y18.69%

EBIT Next 5YN/A

FCF growth 1Y-60.35%

FCF growth 3Y7.47%

FCF growth 5Y-33.2%

OCF growth 1Y-33.1%

OCF growth 3Y6.75%

OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.

What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 5 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.

What is the profitability of SEM stock?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.

What is the earnings growth outlook for SELECT MEDICAL HOLDINGS CORP?

The Earnings per Share (EPS) of SELECT MEDICAL HOLDINGS CORP (SEM) is expected to grow by 13.52% in the next year.

Can you provide the dividend sustainability for SEM stock?

The dividend rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 5 / 10 and the dividend payout ratio is 21.99%.